SCHEMBL14286149

SCHEMBL14286149

O=C(c1cc(-c2nnnn2-c2c(F)ccc(F)c2F)c[nH]1)N1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.41
MAPK10 P53779 1/20 0.41
ATP4A P20648 2/20 0.38
ATP4B P51164 2/20 0.38
HPGD P15428 3/20 0.36
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
ALPL P05186 2/20 0.33
LMNA P02545 1/20 0.33
HRH4 Q9H3N8 4/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14600770 0.79 HRH4 (0.36) HPGDCYP11B1CYP11B2ALDH1A1F2
SCHEMBL14286147 0.78 MAPK1 (0.37) MAPK1MAPK10HPGDALDH1A1HTT
SCHEMBL14286148 0.71 MAPK1 (0.42) MAPK1MAPK10ATP4AATP4BHPGD
SCHEMBL5037079 0.70 KCNN4 (0.40) ALDH1A1
SCHEMBL14286151 0.69 ADORA2A (0.39) MAPK1MAPK10
SCHEMBL5038382 0.68 MAPK1 (0.49) MAPK1MAPK10ATP4AATP4BHPGD
SCHEMBL10067969 0.68 HRH4 (0.35) HPGDALDH1A1HTTF2F10
SCHEMBL14286171 0.68 MAPK1 (0.52) MAPK1MAPK10ATP4AATP4BHPGD
SCHEMBL5047846 0.66 MAPK1 (0.47) MAPK1MAPK10ATP4AATP4BHPGD
SCHEMBL14286136 0.65 MAPK1 (0.44) MAPK1MAPK10ATP4AATP4BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7314885-B2 Pyrrole compounds useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-01 US disclosed
US-7314885-B2 Pyrrole compounds useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-01-01 US disclosed